RECRUITING

PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.

Talk to us

Conditions

Chronic Obstructive Pulmonary DiseaseChronic Obstructive Lung DiseaseChronic Obstructive Airway DiseaseQuality Improvement Program

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

A 3-year cluster randomized controlled trial of the impact of a quality improvement and clinical decision support package versus usual care for patients with modifiable high-risk chronic obstructive pulmonary disease with or without a current diagnosis.

Official Title

Pragmatic Evaluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD (PREVAIL)

Quick Facts

Study Start:2022-09-23
Study Completion:2026-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05306743

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Primary Care Teams (PCTs) must be able to function as a single randomization unit with low risk of contamination between participants and physicians due to the absence of blinding in the intervention (see section 8.8 for details on blinding).
  2. * PCT must have a sufficient number of patients meeting modifiable high-risk patient criteria (see section 8.1 on sample size estimates).
  3. * PCT must express willingness to be randomized to either receive the CONQUEST program initially, or usual care until program roll-out to the delayed intervention arm.
  1. * PCTs that are in the process of, or planning to change EHR software provider or practice ownership within the trial outcome evaluation period
  2. * PCTs engaged in active research studies or COPD related Quality Improvement Programs which might impact the ability to implement CONQUEST program.

Contacts and Locations

Study Contact

David Price, FRCGP
CONTACT
+65 3105 1489
dprice@opri.sg

Study Locations (Sites)

University of Colorado
Denver, Colorado, 80309
United States
Mount Sinai
New York, New York, 10029
United States
MetroHealth
Cleveland, Ohio, 44109
United States

Collaborators and Investigators

Sponsor: Observational and Pragmatic Research Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-09-23
Study Completion Date2026-12

Study Record Updates

Study Start Date2022-09-23
Study Completion Date2026-12

Terms related to this study

Keywords Provided by Researchers

  • Chronic Obstructive Pulmonary Disease
  • Chronic Obstructive Lung Disease
  • Chronic Obstructive Airway Disease
  • Quality Improvement Program

Additional Relevant MeSH Terms

  • Chronic Obstructive Pulmonary Disease